Ashok Patidar
Pune, MH 411007, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Rationalized combinatorial targeting of immune co-receptors leads to tumor regression.
Journal: Cytokine
Published: April 30, 2025
TLR2, TLR3, TLR4, TLR9 and TLR11 expression on effector CD4+ T-cell subsets in Leishmania donovani infection.
Journal: Experimental parasitology
Published: February 19, 2023
TLR induced IL-27 plays host-protective role against B16BL6 melanoma in C57BL/6 mice.
Journal: Cytokine
Published: January 20, 2022
Berberine mediates tumor cell death by skewing tumor-associated immunosuppressive macrophages to inflammatory macrophages.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 05, 2021
Interdependencies between Toll-like receptors in Leishmania infection.
Journal: Immunology
Published: February 03, 2021
TLR2 dimer-specific ligands selectively activate protein kinase C isoforms in Leishmania infection.
Journal: Immunology
Published: January 01, 2021
Barley beta-Glucan and Zymosan induce Dectin-1 and Toll-like receptor 2 co-localization and anti-leishmanial immune response in Leishmania donovani-infected BALB/c mice.
Journal: Scandinavian journal of immunology
Published: May 09, 2020
Interleukin-27 Functional Duality Balances Leishmania Infectivity and Pathogenesis.
Journal: Frontiers in immunology
Published: March 09, 2020
Peptidoglycan-treated tumor antigen-pulsed dendritic cells impart complete resistance against tumor rechallenge.
Journal: Clinical and experimental immunology
Published: December 06, 2019
Tumor Arrests DN2 to DN3 Pro T Cell Transition and Promotes Its Conversion to Thymic Dendritic Cells by Reciprocally Regulating Notch1 and Ikaros Signaling.
Journal: Frontiers in immunology
Published: October 16, 2019
LmjMAPK10 offers protection against Leishmania donovani infection.
Journal: Parasite immunology
Published: July 17, 2019
Last Updated: 09/26/2026